The presence of additional cytogenetic abnormalities (ACAs) or Philadelphia chromosome variants do not adversely affect the achievement of treatment-free remission in chronic myeloid leukemia

Am J Hematol. 2024 Jun;99(6):1175-1176. doi: 10.1002/ajh.27307. Epub 2024 Mar 28.

Authors

Fadi G Haddad¹, Koji Sasaki¹, Ghayas C Issa¹, Elias Jabbour¹, Hagop Kantarjian¹

Affiliation

¹ Department of Leukemia, The University of Texas MD Anderson Cancer Center, Houston, Texas, USA.

PMID: 38546372
DOI: 10.1002/ajh.27307

No abstract available

Publication types

Letter

MeSH terms

Adult
Aged
Chromosome Aberrations*
Female
Humans
Leukemia, Myelogenous, Chronic, BCR-ABL Positive* / drug therapy
Leukemia, Myelogenous, Chronic, BCR-ABL Positive* / genetics
Male
Middle Aged
Philadelphia Chromosome*
Remission Induction*